Similarly, resveratrol was shown to inhibit DNMT1 activity and expression at the BRCA1 promoter, leading to promoter hypomethylation and the reactivation of BRCA1 in breast cancer cells [152,154]. This evidence concerns the gene BRCA1 and breast cancer.